Harvard Catalyst supports Harvard-affiliated investigators with seed funding for early-stage translational research, fostering collaboration across institutions and disciplines to address themed priorities.
Funder: Harvard University
Due Dates: January 6, 2027 (Round 3: Increasing the Impact of Clinical Research on Human Health)
Funding Amounts: $25,000–$50,000 per award; up to 8 awards for Round 3
Summary: Harvard Catalyst provides seed funding for early-stage translational research through themed pilot grants that foster cross-institutional and interdisciplinary collaboration.
Key Information: Pilot funding is available to Harvard-affiliated investigators.
Harvard Catalyst at Harvard University offers pilot grants and prizes to support Harvard-affiliated investigators conducting early-stage research across the translational spectrum. The program supports work ranging from basic and preclinical investigation to practice-based and population-based research. Its seed funding is intended to foster cross-institutional and interdisciplinary collaboration.
Each request for proposals has a distinct thematic focus within this broad research scope. The current opportunity is Round 3: Increasing the Impact of Clinical Research on Human Health. Previous calls have focused on human sensory systems, access to Harvard University Core Facilities, environmental toxins and health, health disparities, and participation in research studies.